PROTHENA
Prothena Corporation plc is a late-stage clinical company with expertise in protein dysregulation and a pipeline of novel investigational therapeutics with the potential to change the course of devastating rare peripheral amyloid and neurodegenerative diseases. Fueled by its deep scientific expertise built over decades of research, Prothena is advancing a pipeline of therapeutic candidates for a number of indications and novel targets for which its ability to integrate scientific insights around... neurological dysfunction and the biology of misfolded proteins can be leveraged. Prothena’s pipeline includes both wholly-owned and partnered programs being developed for the potential treatment of diseases including AL amyloidosis, ATTR amyloidosis, Alzheimer’s disease, Parkinson’s disease and a number of other neurodegenerative diseases.
PROTHENA
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2012-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.prothena.com
Total Employee:
51+
Status:
Active
Contact:
650 837 8550
Total Funding:
333.1 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Tag Manager WordPress Content Delivery Network Wordpress Plugins Nginx Sitelinks Search Box Euro
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Current Advisors List
Board_member
2012-12-01
Board_member
Current Employees Featured
Radhika Tripuraneni CDO @ Prothena
CDO
Tran B. Nguyen Chief Strategy Officer @ Prothena
Chief Strategy Officer
2021-10-01
Robin Barbour Head of Antibody and Assay Development @ Prothena
Head of Antibody and Assay Development
2012-12-01
Michael J. Malecek CLO and Company Secretary @ Prothena
CLO and Company Secretary
Dennis Selkoe Director @ Prothena
Director
Tran B. Nguyen CFO @ Prothena
CFO
2013-03-01
Brian M Campbell Vice President & Head of Translational Medicine @ Prothena
Vice President & Head of Translational Medicine
2020-11-01
Carol Karp Chief Regulatory Officer @ Prothena
Chief Regulatory Officer
2016-01-01
Gene G. Kinney CEO, President & Director @ Prothena
CEO, President & Director
Wagner M. Zago CSO @ Prothena
CSO
Founder
Stock Details
Investors List
Sofinnova Investments
Sofinnova Investments investment in Post-IPO Equity - Prothena
Key Employee Changes
| Date | New article |
|---|---|
| 2021-10-01 | Prothena Announces Executive Appointments - Oct 01, 2021 |
Official Site Inspections
http://www.prothena.com Semrush global rank: 3.51 M Semrush visits lastest month: 4.21 K
- Host name: ec2-54-92-229-249.compute-1.amazonaws.com
- IP address: 54.92.229.249
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Prothena"
Learn About Our History, Leadership & More - Prothena
Dec 2, 2019 Learn about the Prothena mission, history and leadership responsible for developing therapeutics for neurodegenerative and rare peripheral amyloid diseases ... These …See details»
Prothena Biosciences - expertise in protein dysregulation
With a growing pipeline of programs based on this scientific approach, Prothena is advancing therapeutics for neurodegenerative and rare peripheral amyloid diseases, which affect millions …See details»
Our mission is to make a real impact for patients - Prothena
Prothena Corporation PLC is a late-stage clinical biotechnology company with expertise in protein dysregulation. Fueled by a deep scientific expertise built over decades of research, Prothena …See details»
Prothena - Crunchbase Company Profile & Funding
Prothena Corporation plc is a late-stage clinical company with expertise in protein dysregulation and a pipeline of novel investigational therapeutics with the potential to change the course of devastating rare peripheral amyloid and …See details»
Prothena Announces Leadership Team Updates
Sep 27, 2024 Chad will join Prothena’s executive leadership team and will report to Gene Kinney, Ph.D., President and Chief Executive Officer. Hideki Garren, M.D., Ph.D., will pursue …See details»
Prothena - Leadership Team - The Org
The Leadership Team at Prothena is responsible for guiding the strategic direction and operational execution of the company. Comprising key executives across various disciplines, …See details»
Prothena Corporation - LinkedIn
Prothena is a late-stage clinical biotechnology company with expertise in protein dysregulation and a diverse pipeline of novel investigational therapies for neurodegenerative and rare peripheral ...See details»
Home | Prothena
About Prothena's investigational drug candidates. This site contains medical and scientific information related to Prothena's products and/or uses that have not been approved by any regulatory authority (e.g., FDA, EMA). If you are a …See details»
Prothena Corporation - LinkedIn
Prothena Corporation | 12,627 followers on LinkedIn. Prothena is a late-stage clinical biotechnology company with expertise in protein dysregulation and a diverse pipeline of novel …See details»
Prothena’s Corporate Fact Sheet | Prothena
Mar 21, 2024 The latest news, insights and resources from Prothena. Prothena’s Corporate Fact Sheet March 21, 2024 / in Fact Sheets, News Center / by Brandon Diaz. Share this story. …See details»
Investors - Corporate Governance - Prothena Corporation plc
Nominating and Corporate Governance Committee Charter (opens in new window). 164 KB. Research and Development Committee Charter (opens in new window)See details»
Prothena Company Profile - Office Locations, Competitors ... - Craft
Oct 29, 2024 Prothena has 5 employees across 2 locations and $91.37 m in annual revenue in FY 2023. See insights on Prothena including office locations, competitors, revenue, financials, …See details»
Prothena - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Prothena . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... Prothena has 15 current employee profiles, including …See details»
Prothena Reports Fourth Quarter and Full Year 2022 Financial …
Feb 23, 2023 Net cash used in operating and investing activities was $5.1 million in the fourth quarter and $109.3 million for the full year of 2022; quarter-end cash and restricted cash …See details»
Hear from Prothena CEO Gene Kinney on the progress made …
Jan 26, 2024 I look forward to another exciting year not only for Prothena but also for the field to generate potentially transformational data in 2024 and beyond. I am proud to do my part and …See details»
Prothena Reports Third Quarter 2023 Financial Results and …
Nov 2, 2023 DUBLIN--(BUSINESS WIRE)-- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built …See details»
Prothena (PRTA) Earnings Date and Reports 2025 - MarketBeat
3 days ago Prothena issued Q3 2024 earnings on November 12, 2024, reporting an EPS of -$1.10, which beat analysts' consensus estimates of -$1.18 by $0.08. Quarterly revenue fell …See details»
Investor Relations - Prothena Corporation plc
Prothena Corporation plc (Nasdaq: PRTA) is a late-stage clinical biotechnology company with expertise in protein dysregulation and a diverse pipeline of novel investigational therapies with …See details»
News Center - View Videos, Articles, & Resources - Prothena
Nov 19, 2024 Prothena Reports Third Quarter 2024 Financial Results and Business Highlights: Nov 05, 2024: Prothena to Report Third Quarter 2024 Financial Results on November 12: Sep …See details»
Donna-Lee Destouche, Head of Clinical Trial Management at …
Feb 28, 2024 The latest news, insights and resources from Prothena. Donna-Lee Destouche, Head of Clinical Trial Management at Prothena, shares her perspective on supporting women …See details»